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ABSTRACT 
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease that could lead to 
joint destruction and disabilities. Around 30-70 million people worldwide are affected by RA. 
Both genetic and environmental factors are involved in the etiology of RA. However, 
researches aiming at understanding the environmental factors leading to RA are relatively few.  
 
Aims: The main aim of this thesis is to investigate occupational risk factors for RA. The sub-
aims are: 1.) To investigate the interaction between the dose of cigarette smoking and silica 
exposure regarding risk of anti-citrullinated protein antibody (ACPA) positive RA among male 
subjects. 2.) To investigate the association between different types of physical workload and 
risk of RA. 3.) To investigate the association between different types of physical workload and 
development of antibodies against collagen type II (anti-CII) in RA. 4.) To investigate the 
association between working in cold environment and risk of RA.  
 
Materials and Methods: This thesis was based on the Swedish Epidemiological Investigation 
of Rheumatoid Arthritis (EIRA) Study, which is a population-based case-control study 
involving more than 3000 incident RA cases and more than 5000 controls recruited between 
1996 and 2014. Information on exposures (i.e. cigarette smoking, silica, physical workload and 
cold work environment) was obtained through self-reported questionnaire. RA cases were 
ascertained based on the ACR 1987 or 2010 criteria. The associations between exposures and 
outcome (risk of developing RA) were estimated using logistic regression by calculating the 
odds ratios (OR) and 95% confidence intervals (CI). Presence of additive interaction between 
risk factors was evaluated by calculating the attributable proportion due to interaction (AP).  
 
Results: As the dose of smoking increased, the magnitude of interaction between silica and 
smoking also increased, with the highest AP value (AP=0.7; 95%CI: 0.4-0.9) observed at 28 
pack-years of smoking. The interaction between silica and smoking among those who quitted 
smoking for ≤10 years was estimated to have an AP of 0.5 (95%CI: 0.1-0.9). The associations 
between different types of physical workload and risk of developing RA ranged from 
1.3(95%CI: 1.1-1.4) to 1.8(95%CI: 1.6-2.0).  The ORs between physical workloads and risk of 
developing anti-CII positive RA was comparable with the corresponding ORs observed 
between physical workloads and risk of developing anti-CII negative RA. Those who reported 
they had worked in cold environment had a 50% higher risk of developing RA than those who 
did not (OR=1.5 (95%CI:1.4-1.7)). 
 
Conclusions: The interaction between smoking and silica depends on the cumulative dose of 
smoking and the effect of interaction could remain even after nearly 10 years of smoking 
cessation. Both exposure to physical workload and exposure to cold work environment were 
found to be associated with an increased risk of developing RA. These factors are new potential 
risk factors for RA and need confirmation. The findings may provide new clues for unraveling 
the etiology of RA and contribute to the endeavor of making RA a preventable and curable 
disease.    
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1 INTRODUCTION 
 
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by inflamed 
synovial tissue which could lead to joint destruction and disabilities. It affects 0.5%-1% of the 
world population. There is no available cause-directed curative therapies for RA, and this 
would not be possible without better understanding of the causes of RA. Aside from genetic 
predisposition, environmental factors play a substantial role in RA etiology. There are vast 
amount of researches on RA focusing on the cellular or molecular level to understand the 
disease pathogenesis. In contrast, relatively few researches on RA are focused on modifiable 
environmental factors. Providing new knowledge on environmental risk factors would 
address patients’ need and desire to understand why they develop the disease and how to 
prevent their family members from suffering from the same disease. Thus, the overall aim of 
this thesis is to increase our knowledge on environmental risk factors of RA.  
 
This thesis is made possible through the use of the Swedish Epidemiological 
Investigation of Rheumatoid Arthritis (EIRA) study, which is a population based case-control 
study. The EIRA study currently possesses one of the world’s largest and most complete data 
that contain both environmental and genetic information about incident RA cases and their 
corresponding controls. This thesis analyzed data from more than 3000 incident RA cases and 
more than 5000 controls recruited between 1996 and 2014. 
 
By using the data from EIRA study, our research group has previously found an 
interaction between smoking and silica with regards to the risk of anti-citrullinated protein 
antibodies (ACPA)-positive RA; however the dose of smoking needed to elicit such 
interaction effect was unknown. Therefore, study I aimed at investigating the interaction 
between silica exposure and dose of smoking as well as between silica exposure and duration 
of smoking cessation, with regard to the risk of developing ACPA-positive RA. 
  
Physical workload is a potential risk factor that needs to be consider for all types of 
joint disease including RA, since the joints are directly involved in performing physical 
workload. The aims of study II and study III were to investigate the association between 
physical workload and risk of RA, as well as the relation between physical workload and 1.) 
RA related gene (HLA-DRB1 shared epitope); 2.) development of two auto-antibodies 
(ACPA and antibodies against type II collagen) in RA. 
 
Another potential risk factor for RA is exposure to cold environment. Coldness has 
been suspected to be associated with arthritis for a long time in human history. Although 
there are many studies that investigated meteorological factors and RA signs and symptoms, 
studies that investigate the association between working in cold environment and risk of 
developing RA in healthy individuals have not been found in the literature. Therefore, study 
IV aimed at shedding some light on this missing knowledge. 
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2 BACKGROUND 
2.1 CLINICAL FEATURES AND CLASSIFICATION OF RHEUMATOID 
ARTHRITIS 
 
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by 
inflamed synovial tissue which may eventually lead to cartilage and joint destruction.1 In 
addition to the inflamed joints, it may also exhibit various extra-articular manifestations, such 
as rheumatoid nodules, vasculitis and interstitial lung disease.2 RA is associated with 
increased mortality and several systemic comorbidities including cardiovascular disease, 
interstitial lung disease and cerebrovascular events.3,4 
 
Clinical features of RA include swollen and tender joints, morning joint stiffness, 
elevated level of C-reactive protein or erythrocyte sedimentation rate. However, these 
features are not specific for rheumatoid arthritis, since similar features are also seen in other 
types of arthritis such as psoriatic arthritis and some inflammatory connective tissue 
diseases.5 Although there are no specific diagnostic criteria for rheumatoid arthritis, 
classification criteria were developed to facilitate the identification of a homogenous 
population for research purposes and for supporting diagnosis. 
 
The 1987 American College of Rheumatology (ACR) criteria (table 1) was created 
based on studies from subjects with well-established RA.6  This method has a high sensitivity 
and specificity for classifying established RA, but has a low sensitivity and specificity in 
classifying early RA.7 Clinical studies have shown that identifying and treating RA patients at 
an early stage can achieve better treatment outcome by slowing or preventing bone/cartilage 
damage, decreasing disability and increasing the rate of disease remission.8,9 To overcome the 
limitation of the 1987 ACR criteria, the 2010 ACR/EULAR criteria (table 1) was developed 
using cohorts of subjects with early RA.10 It includes additional serological markers 
(rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA)), long symptom 
duration and laboratory markers of systemic inflammation.   
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Table 1:  Classification Criteria for Rheumatoid Arthritis (RA) 
  
1987 ACR Classification 
Criteria 
2010 ACR/EULAR Classification 
Criteria  
criteria 1. Morning stiffness 
(at least one hour) 
2. Arthritis in three or 
more join areas 
3. Arthritis of hand 
joints (≥1 swollen joints) 
4. Symmetric arthritis 
5. Rheumatoid 
nodules 
6. Serum RF 
7. Radiographic 
changes (erosions) on X-
rays of hands 
1. Joint involvement (0-5) 
x medium-large joint a (0) 
x 2-10 medium-large joints (1) 
x 1-3(small jointsb (large joint 
not counted) (2) 
x 4-10 small joints (large joint 
not counted) (3) 
x >10 joints (at least one small 
joints) (5) 
2. Serology (0-3) 
x negative RF and negative 
ACPAc (0) 
x low positive RA or low 
positive ACPAd (2) 
x high positive RA or high 
positive ACPAe (3) 
3. Acute phase reactants 
x normal CRP and normal ESRf 
(0) 
x abnormal CRP or abnormal 
ESR (1) 
4. Duration of symptoms (0-1) 
x <6 weeks (0) 
x ≥6 weeks (1) 
applicable 
for 
patients with established RA patients with early or established RA 
positive in 
cases 
Four of the seven criteria must be 
present. Criteria 1-4 must have 
been present for at least six 
weeks. 
Scoring ≥6 points. 
In the presence of typical erosions seen in 
light of an inflammatory disorder or long-
standing disease previously satisfying the 
classification criteria, no other points need 
to be obtained for the classification of RA. 
Scoring points are shown in parentheses. 
a Large joints refer to shoulders, elbows, hips, knees, and ankles. 
bSmall joints refer to the metacarpophalangeal joints, proximal interphalangeal joints, second 
through fifth metatarsophalangeal joints, thumb interphalangeal joints, and wrists. 
cNegative refers to IU values that are less than or equal to the upper limit of normal (ULN) 
for the 
laboratory and assay. 
dlow-positive refers to IU values that are higher than the ULN but ≤3 times the ULN for the 
laboratory and assay.  
ehigh-positive refers to IU values that are >3 times the ULN for the laboratory and assay. 
Where rheumatoid factor (RF) information is only available as positive or negative, a positive 
result should be scored as low-positive for RF. 
fNormal/abnormal is determined by local laboratory standards.  
RF=rheumatoid factor; ACPA,=anti-citrullinated protein antibody; CRP= C-reactive protein; 
ESR,=erythrocyte sedimentation rate 
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2.2 TREATMENT STRATEGY FOR RHEUMATOID ARTHRITIS 
 
Therapeutic approaches for RA have evolved from non-steroidal anti-inflammatory 
drugs (NSAIDs) and glucocorticoids to disease-modifying anti-rheumatic drugs (DMARDs). 
DMARDS target inflammation, reduce pain and swelling, improve physical function and 
modify or limit progressive joint damage.5 According to the EULAR recommendations, 
conventional DMARD, preferably methotrexate, should be the choice for initial treatment.11 
If a patient failed to respond to initial conventional DMARDS, then he/she may be switched 
to biologic DMARDS or Janus kinase inhibitors and may also be treated with a combination 
of the numerous available drugs.5  
 
Although advancements in therapeutic strategies over the past years have led to better 
disease activity control for RA patients, substantial portion of patients fail to respond to initial 
methotrexate treatment or first anti-TNF treatment,12 and approximately 20% of patients 
continue to suffer from pain, joint damage and disability.13 Failure of initial treatments would 
lead to a series of experimentation with other available therapeutics, and consequently would 
prolong and increase patients’ disease burden. Timely identification and application of 
effective treatment would improve the efficacy of treatment management and prevent 
manifestation of debilitating RA. Better understanding of the causes or pathogenesis of RA is 
needed in order to provide cause-directed curative therapies and ultimately prevent RA. 
2.3 PATHOGENESIS OF RHEUMATOID ARTHRITIS 
2.3.1 Auto-Antibodies  
 
RA is a disease caused by immune dysregulation. One of the perpetrators of immune 
dysregulation is the development of excessive auto-antibodies. Examples of auto-antibodies 
found in RA include rheumatoid factor (RF), anti-citrullinated protein antibody (ACPA) and 
anti-collagen type II (anti-CII) antibodies. 
 
Rheumatoid factor (RF) are antibodies that bind to the Fc portion of IgG antibody. RF 
possesses diagnostic and predictive value for RA. It can be detected in around two thirds of 
RA patients, but can also be found in patients with other diseases such as Sjögren’s 
syndrome, hepatitis and tuberculosis, and in a small proportion of healthy individuals.14 
Despite its low specificity, the presence of RF is associated with disease severity and it has 
been used as a biomarker for diagnosis and classification of RA for more than three 
decades.15 
 
The diagnostic value of antibodies to citrullinated antigens (ACPAs) was discovered 
20 years ago.16,17 The presence of these antibodies is restricted to a subset of RA patients 
characterized by its association with certain HLA-DR alleles and cigarette smoking.18  Unlike 
RF, ACPA has a high specificity (around 95%) for RA.19 Individuals that are positive for RF 
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and/or ACPA are often called “seropositive” and constitute approximately 2/3 of the 
population with newly onset RA.  
 
Approximately 15 years ago, Rantapaa et al. and Nielen et al. discovered that 
antibodies against citrullinated peptide can be detected in blood samples of individuals 
several years before they eventually developed RA.20,21 The titer of ACPA increases when 
individuals get close to the onset of RA, whereas very few patients develop ACPAs after 
onset of RA.20,21 ACPA positive patients have different clinical phenotypes and outcomes 
when compared to ACPA-negative RA. ACPA positive RA patients tend to have more 
aggressive disease phenotype, more bone erosion and worse disease outcome.22 ACPA-
positive RA and ACPA-negative RA also represent two distinct disease subsets in which the 
underlying disease pathogeneses have partially different molecular mechanisms.23 Therefore, 
it is important to analyze these two subsets separately when studying RA etiology. 
 
Anti-CII antibodies are antibodies that recognize type II collagen of the articular 
cartilage and plays a role in cartilage destruction. One of the functions of articular cartilage is 
to facilitate mechanical stress loaded on joints.24 Notably arthritis induced by immunization 
with collagen type II is one of the main arthritis models in mice and rats.25 However, 
immunity to native and unmodified collagen II is rare in humans. Anti-CII is present in 6-9% 
of RA patient at diagnosis and the titer of anti-CII decreased gradually after diagnosis.26 In 
contrast to ACPA, the presence of anti-CII predicts lower degree of inflammation during the 
disease course and better disease outcome.26   
 
The presence of these different auto-antibodies in RA suggest that loss of immune 
tolerance is a key event in the pathogenesis of seropositive RA. The factors that contribute to 
the break of immune tolerance remains to be elucidated. Identification of new environmental 
factors would warrant a better understanding of the event cascades leading to the 
development of these pathogenic auto-antibodies. 
2.3.2 Genetic Factors  
 
RA is caused by the interplay between genetic and environmental factors. The 
heritability of RA is estimated to be around 37-65%,27 and is found to be higher among for 
sero-positive disease (50%) subset than among sero-negative (20%) subset.28 The relatively 
low heritability of RA especially among the sero-negative subgroup suggests that 
environmental factors play a sizeable role in the etiology of RA.  
 
 
 
 
 
 
  7 
 According to genome wide association studies, the HLA-DRB1 locus is the dominant 
genetic risk factors for RA.29 The HLA-DRB1 alleles encode for common amino acid motifs 
including the shared epitope (SE), which is located in the β-chain of the MHC molecule 
involved in antigen presentation and selection of T-cell repertoire. The role of these genes 
indicate that immune mechanisms, particularly peptide binding, are strongly involved in the 
pathogenesis of seropositive RA. Notably, the disease causing effects of these genes are 
triggered by environmental factors. Smoking have been shown to increase the risk of 
developing ACPA-positive RA especially among individuals with HLA-DRB1 risk alleles.30 
The presence of gene-environment interaction between the HLA-DRB1 alleles and smoking 
highlights the importance of considering gene-environment interaction when investigating the 
etiology of RA. 
 
2.3.3 Pre-RA Stages 
 
Systemic autoimmunity in RA may begin many years before symptom appearance and 
diagnosis. Over the years, many researches have delved into research questions related to 
events that occur before clinical symptoms of RA become evident. In 2011, the EULAR 
Study Group for Risk Factors for Rheumatoid Arthritis developed a nomenclature to describe 
various phases or events that could occur before diagnosis of RA. 
 
There are five identified phases that an individual at risk of RA might undergo 
(figure1).31 The development of RA can start as early as having the related genes and being 
exposed to certain environmental risk factors (phase A and B). Phase C pertains to 
individuals with systemic autoimmunity associated with RA. Phase D denotes individuals 
showing symptoms without clinical arthritis. Phase E refers to individuals with unclassified 
arthritis. Some individuals may develop from phase A or B to phase C (having systemic 
autoimmunity), while other individuals may skip phase C and proceed directly to phase D or 
phase E or phase F. 
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Several studies have recruited cohorts who are in the at-risk phase of RA and 
performed observational studies. Some studies looked into potential pre-RA therapeutic 
intervention that could delay or halt the development of RA among the at-risk population.32-35 
Other studies aimed at developing algorithmic model based on the known risk factors and 
biomarkers to predict the risk of developing RA.36 
 
Given the above-mentioned knowledge, modification of lifestyle or environmental risk 
factor is thus pivotal in preventing RA from a very early stage. For example, smoking 
cessation could have substantial RA preventive effect especially for the individuals with 
genetic predisposition. Since better preventive strategies are needed, it is necessary to identify 
and validate more environmental risk factors. When searching for potential lifestyle and 
environmental risk factors, taking patients’ concern and perspective into considerations could 
be valuable. Clinicians often receive questions from patients on whether musculoskeletal 
workload or exposure to cold environment are contributing factors to their disease. There is, 
however, a lack of scientific studies related to these two commonly asked questions. 
Therefore, one of the aims of this thesis is to provide clues to these two commonly asked 
questions by conducting epidemiologic studies to investigate whether occupation physical 
workload and cold work environment are associated with the development of RA. 
 
3 EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS 
 
RA affects between 0.5% to 1% of the world population.37 Women are two to three 
times more likely to have RA than men.38 Higher prevalence was observed in northern 
hemisphere (i.e. Northern Europe and North America) than southern hemisphere.39 Notably, 
Native American groups including the Pima, Yakima and Chippewa have very high 
prevalence.40  In Sweden, the incidence is 41 per 100,000, with 56/100,000 for women and 
Figure 1. The possible 5 phases of RA development. The open circles represent painful 
joints but not swollen. The solid circles/shapes represent joints with clinically apparent soft 
tissue swelling. (Adapted from Raza et al. 2014).  
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25/100,000 for men.41 The incidence rate increases with age and highest incidence is 
observed in the 70-79 years age group. 
 
Rheumatoid arthritis incurs substantial socioeconomic and individual burden. This 
burden may comprise of hospital care, drug cost, loss of work capacity due to physical 
function disability and declined quality of life.  In Sweden, the annual societal cost was 
estimated to be around €23 000 per prevalent RA case among the non-pension age 
population, and around €6400 per prevalent RA case among the pension age population.42 
These costs correspond to 2-3 times higher cost as compared with the general population with  
no RA.42 
 
3.1 ENVIRONMENTAL RISK FACTORS 
3.1.1 Cigarette Smoking 
 
Among all the environmental risk factors studied for RA, cigarette smoking is the most 
well-studied factor. Smokers have approximately 2-fold higher risk of RA than non-
smokers.43-46 Furthermore, a dose-response effect has been observed in several studies. 43,44,46 
The association is subsequently found to be mainly confined to the anti-citrullinated 
protein/peptide antibody (ACPA)-positive RA;44 and the risk appears to be not due to 
nicotine but due to some inhaled particles.47 A few studies found a reduction, but not 
elimination of RA risk after 10-20 years of smoking cessation.43,46,48,49 
3.1.2 Silica 
 
Exposure to silica is a well-defined airborne hazard present in mining, quarrying, 
drilling and some electronic industries.  Silica dust has been postulated as an etiologic agent 
for several systemic autoimmune diseases including RA.50-52 Our research group has 
previously observed an association between silica exposure and increased risk of sero-
positive RA (odds ratio (OR) 1.6 for ACPA-positive RA and 1.9 for rheumatoid factor 
positive RA).53,54 We also observed an interaction effect between silica exposure and current 
smoking regarding ACPA-positive RA (attributable proportion due to interaction was 60%) 
and the OR was 7.4 among those who were both silica exposed and current smokers 
compared with unexposed.54  However, the amount of smoking that could elicit this 
interaction effect is unclear. 
3.1.3 Other Environmental Risk Factors 
 
Several environmental risk factors for RA have been studied as shown in table 2. 
Infectious agents have been suspected to be associated with RA for several decades.  There 
are increasing number of studies focusing on the association between Porphyromonas 
gingivalis and risk of RA. Porphyromonas gingivalis is considered as one of the main 
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organisms causing periodontal disease. It could citrullate peptides through peptidylarginine 
deiminase enzymes; thus, could potentially trigger the production of ACPA. However, this 
hypothesized association between Porphyromonas gingivalis and RA has not been supported 
by population-based studies.55,56 Moderate alcohol consumption and taking omega-3 fatty 
acid supplements or oral contraceptives were observed to lower the risk of RA.57-59  
Hormonal factors and breastfeeding have been a longstanding interest for many 
epidemiological investigations concerning RA risk factors,60-62 since RA is a disease with 
higher prevalence in women than men. Overall, there is a paucity of information on 
environmental triggers of RA, and the number of scientific researches dedicated to 
environmental risk factors for RA is relatively few when compared to experimental 
researches.   
 
 
 
Table 2. Environmental Factors Related to Rheumatoid Arthritis 
Factors generally deemed as associated with RA Risk 
x smoking, silica 
x lower socioeconomic status 
x educational attainment 
 
x high BMI 
x high birthweight 
 
Factor generally deemed as associated with RA protection 
x moderate alcohol consumption x fish/omega-3 fatty acid 
consumption 
 
Inconclusive Factors 
x diet (red meat, proteins, fruit, 
caffeine etc.) 
x psychological stress 
x textile dust 
x microbes, infectious agent 
(Porphyromonas gingivalis, 
Escherichia coli and Epstein-
Barr virus) 
x air pollution 
x breastfeeding 
x oral contraceptives 
x low Vitamin D level 
x occupation in manufacturing 
sector 
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4 PHYSICAL WORKLOAD  
 
Physical workload and physical activities or exercises differ in quantity, intensity and 
duration of mechanical stress exerted on the joint and synovia. Examples of different kinds of 
physical workload at work places are shown in table 3. Physical workload is considered as a 
risk factor for non-autoimmune osteoarthritis and low back pain.63-65  Exposure to vibration 
has previously been studied as a potential risk factor for RA, but the study size was small.50 
Since the joints and muscles are directly affected by physical workload, it is a potential risk 
factor to consider for all types of joint diseases including RA. However, studies that 
systematically investigate the association of occupational exposure to different types of 
physical workload and risk of developing RA have not been found in the literature.  
 
 
Table 3. Examples of Occupational Physical Workload 
1. bending/turning in a repetitive manner several times per hour 
2. repetitive hand or finger movements several times per minute, for example typing or 
sorting 
3. lift or carry objects heavier than 10 kg 
4. performing precision work, such as fine mechanics, clock-making or dental work, for 
more than a total of 2 hours per day 
5. work movements where hands are placed below knee level for more than a total of 30 
minutes per day, for example floor or ground work. 
6. work movements where hands are placed above shoulder level for more than a total of 
30 minutes per day. 
7. vibration, such as sitting in a car , boat , airplane, tractor or lorry or using hand-held 
vibrating machines. 
 
5 WORKING IN COLD ENVIRONMENT 
 
Cold exposure at work may be derived from exposure to cold air, cold water or cold 
surfaces. Working in cold condition may have several adverse effects on human health. It 
may affect respiratory illnesses such as asthma or chronic obstructive pulmonary diseases,66,67 
musculoskeletal illness such as back and neck pain,68 69 cardiovascular disease such as acute 
myocardial infarction ,70,71  and dermatological illnesses such as cold urticaria and pernio 
(chilblains).72,73  It may also cause various cold associated injuries or symptoms such as 
frostbite, shortness of breath and numbness.74 Both cold indoor and cold outdoor work have 
been associated with musculoskeletal pain, aches or muscle weakness.69,75-77 
 
Coldness has been suspected to be associated with arthritis for a long time in human 
history. Around 400 B.C. the Greek physician Hippocrates mentioned in his book “On Air, 
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Waters and Places” about the influence of climate and weather conditions on joints. 
Interestingly, the English word “rheumatism” is known or translated as “feng shi bing” (风湿
病 ) in Chinese, which literally means “wind wet disease”. According to an influential 
Chinese traditional medicine book “The Medical Classic of Yellow Emperor”, written more 
than 2000 years ago, rheumatism is considered as a disease caused by wind, coldness and 
wetness. 
 
Some RA patients believe that they can predict weather changes based on their 
symptoms. RA disease activity and its association with seasonal changes and weather 
variables such as low temperature, sunshine and atmospheric pressure have been studied.78,79 
RA related pain have been hypothesized to be correlated with temperature, humidity, 
sunshine and atmospheric pressure,80 but a systematic review of 9 studies reported that there 
is no evidence of a correlation.81 Although there are many studies that investigated 
meteorological factors and RA signs and symptoms, studies that investigate the association 
between working in cold environment and risk of developing RA in healthy individuals has 
not been found in the literature. 
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6 AIMS 
The main aim of the thesis is to identify occupational risk factors for RA. 
 
The specific aims of the thesis are: 
 
x Study I: 
To investigate the interaction between silica and 1.) dose of smoking as well as 
2.) duration of smoking cessation with regards to the risk of developing ACPA-
positive RA among males. 
 
x Study II:  
1.) To investigate the association between occupational physical workload and 
risk of developing RA (overall), ACPA-positive RA and ACPA-negative RA. 
2.) To investigate the interaction between physical workload and the shared 
epitope gene with regards to the risk of developing ACPA-positive RA. 
 
x Study III: 
To investigate the association between occupational physical workload and the 
development of antibodies against type II collagen (anti-CII) in RA patients 
 
x Study IV:  
1.) To investigate the association between working in cold environment and risk 
of developing RA(overall), ACPA-positive RA and ACPA-negative RA. 
2.) To investigate the interaction between working in cold environment and 
physical workload.  
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7 MATERIALS AND METHODS 
 
This thesis is based on the Swedish Epidemiological Investigation of Rheumatoid 
Arthritis (EIRA) Case-Control Study. Study I analyzed only male participants recruited from 
1996-2014.  Study II and IV involved both male and female EIRA participants recruited 
from 1996-2014. Study III included cases recruited from 1996 to 2006 and controls recruited 
from 1996-2014.  
7.1 STUDY DESIGN 
 
Although EIRA is an on-going population-based case-control study, this thesis only 
included data collected from 1996 to 2014. The study base is comprised of subjects aged 18 
and above living in the middle or southern part of Sweden. 
7.1.1 Identification of Cases and Controls 
 
Incident RA cases were defined as those who were newly diagnosed by 
rheumatologists with RA based on the American College of Rheumatology (ACR) 1987 or 
ACR 2010 criteria. Incident cases were recruited from all hospital-based rheumatology units 
and almost all private rheumatology clinics in the study area. The mean time from the 
appearance of first disease symptom to diagnosis was 10 months. The year when the first 
disease symptom appeared was defined as index year. 
 
Controls were randomly selected from the Swedish population register and matched 
with the cases by age, sex and residential area. From 1996-2006, each incident case was 
matched with one control. From 2006 onwards, two controls were matched to each incident 
case. If a case was later revealed to be not fulfilling the inclusion criteria, his/her 
corresponding controls were retained in the study and were included in the non-matched 
analyses. 
7.1.2 Data Collection 
 
Cases were given a questionnaire and invited to donate a blood sample when they 
received their diagnosis at the clinic. Questionnaires for controls were sent by post.  Unclear 
or missing answers in the questionnaires were clarified and completed by trained staffs 
through phone calls or mail. In total, 3724 (94%) of the cases and 5935 (77%) of the controls 
completed the questionnaire. Blood samples were collected from 99% of the cases and 55% 
of the controls who completed the questionnaire.  
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7.2 EXPOSURE ASSESSMENT AND CLASSIFICATION 
7.2.1 Cigarette Smoking 
 
Current smokers were defined as individuals who reported they had regularly smoked 
cigarettes during the index year. Past smokers were defined as subjects who had smoked 
cigarettes before but not during the index year. Never smokers were defined as subjects who 
had never smoked cigarettes. Cumulative dose of smoking was expressed in pack-years. One 
pack-year is equivalent to smoking 20 cigarettes per day for 1 year. Among past smokers, 
duration of smoking cessation was defined as the number of years since quitting smoking. 
Subjects who smoked pipe or cigar were excluded. 
7.2.2 Silica 
 
Subjects who reported they were exposed to rock drilling, stone crushing and stone dust 
were considered as exposed to silica. Occupations that involved rock drilling, stone crushing 
and stone dust were found to be highly exposed to silica.82,83  
7.2.3 Occupational Physical Workload 
 
Information on physical workload exposure was collected by means of questionnaire 
shown in table4. The validity of the questions to assessed physical workload exposure was 
found to be acceptable in other studies,84-86 and the reproducibility and validity were further 
improved when the exposure is dichotomized. Subjects who answered: “never or rarely” or 
“not at all” were considered as unexposed to the type of physical workload in question. 
Subjects who gave all other answers except ‘not working’ were defined as exposed to the 
particular type of physical workload in question. Those who answered not working at 
baseline were excluded from the baseline exposure analysis. Similarly, those who answered 
not working at five years before baseline were also excluded from the 5 years exposure 
analysis. 
 
 
 
 
Table 4. Physical Workload Questionnaire 
1. Does/did your work require you to bend over or turn in a repetitive manner  
   several times per hour?  
             Currently:     Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
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2. Does/did your work involve performing repetitive hand- or finger-movements several 
times per minute? (for example, typing or sorting)   
             Currently:     Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
  
3. Do/did you lift or carry objects heavier than 10 kg?   
             Currently:      Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
  
4. Does/did your work require you to perform precision work for more than a total of two 
hours per day? (for example, fine mechanics, clock-making or dental work)   
             Currently:       Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
  
5. Does/did your work involve movements where your hands are placed below knee level 
for more than a total of 30 minutes per day?  (for example, floor or ground work) 
Currently:      Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
  
6. Do/did you perform work where your hands are/were placed above shoulder level for 
more    than a total of 30 minutes per day?   
Currently:      Five years ago: 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
1. never or rarely 
2. 1-3 days/month 
3. 1 day/week 
4. 2-4 days/week 
5. every working day 
6. not working 
  
7. What proportion of your working day do/did you work on a vibrating floor or seat? 
 (for example, in a car, boat, aeroplane, tractor, or lorry)   
Currently:      Five years ago: 
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1. not at all 
2. ¼ time 
3. ½ time 
4. ¾ time 
5. full-time 
6. not working 
1. not at all 
2. ¼ time 
3. ½ time 
4. ¾ time 
5. full-time 
6. not working 
  
8. What proportion of your working day do/did you work using vibrating hand-held 
machines?(for example, power drill, sander, nail gun, chainsaw, levers, steering wheels, 
etc.)  
Currently:      Five years ago: 
1. not at all 
2. ¼ time 
3. ½ time 
4. ¾ time 
5. full-time 
6. not working 
1.    not at all 
2.    ¼ time 
3.    ½ time 
4.    ¾ time 
5.    full-time 
6.    not working 
 
7.2.4 Working in Cold Environment 
 
Information on exposure to cold work environment was collected through the questions 
shown in table 5. Subjects were asked whether or not they had ever worked in the cold and 
whether or not they had ever worked outdoor. Those who reported they had worked in the 
cold but never outdoor were considered as exposed to cold indoor work environment. Those 
who reported they had worked in the cold and outdoor environment, and the time periods of 
working in the cold and working outdoor coincide, were considered as exposed to cold 
outdoor work environment. 
 
When the first year of exposure to cold work environment came after the year when the 
first disease symptom appeared (i.e. index year), the exposure status was regarded as 
unexposed. Subjects whose first year of exposure to cold work environment was the same as 
the index year were excluded (21 cases (0.6%) and 10 controls (0.2%)). Current exposed 
were defined as those who had been working in the cold environment before index and were 
still working in the cold environment during index year. Past exposed were defined as those 
who had been working in the cold environment before index year but not at index year.  
 
Table 5. Questionnaire for Working in Cold Environment 
 Time Period 1 Time Period 2 
 
No Yes 
from-to 
what 
year 
number of 
hours/week 
from-to 
what 
year 
number of 
hours/week 
work in the cold       
outdoor work       
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7.3 ANTIBODY ASSAYS AND GENOTYPING 
 
The level of ACPA in the serum samples was measured using enzyme-linked 
immunosorbent anti-CCP2 assay (Immunoscan RA Mark2, Euro-Diagnostica, Malmö, 
Sweden). The cut-off value for positive result was ≥25 units/mL.  
 
The level of anti-CII in the serum samples was measured using ELISA. The cut-off 
value for positive result was 29AU/mL. ELISA readings that showed non-specific binding 
were treated separately.26 
 
HLA-DRB1 genotyping was performed using sequence-specific primer-PCR (DR low-
resolution kit; Olerup SSP, Saltsjöbaden, Sweden). HLA-DRB1*01, HLA-DRB1*01*04, 
HLA-DRB1*01*10 were defined as shared epitope.30 
 
7.4 POTENTIAL CONFOUNDERS 
 
Potential confounders included in the analyses were: educational level (university 
degree, yes or no) body mass index (BMI, <25 kg/m2 or ≥ 25 kg/m2), occupational class 
(manual workers and non-manual employees), alcohol consumption (non-drinkers, low, 
moderate, high), cigarette smoking(<10 pack-years, 10-19 pack-years and ≥20 pack-years) 
(except for study I), silica (rock-drilling, stone crushing or stone dust, yes or no) (for study 
II and IV), and recruitment time period (1996-2006 and 2006-2014).  
 
7.5 STATISTICAL ANALYSIS 
 
The association(s) between exposure(s) and outcome(s) was/were assessed by 
calculating the odds ratios (OR) and 95% confidence interval(CI) using logistic regression. 
The exposures and outcomes for each study were shown in table 6. Both conditional and 
unconditional logistic regression were performed, but the results from both ways of analysis 
did not differ substantially. The final results shown in the results section were obtained using 
unconditional logistic regression with adjustment for the matching variables (age, sex and 
residential area), since this alternative generated results with greater precision. Adjustments 
for potential confounding factors were performed by adding the potential confounder as an 
additional covariate into the model.  
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Table 6. Outcome and Exposure for Study I to Study IV 
 Outcome Exposure 
Study I  ACPA-positive RA among male silica (yes/no) 
smoking ( current, past) 
Study II RA(overall) ; ACPA-positive RA; ACPA-negative RA 7 types of PW 
Study III anti-CII positive RA; anti-CII negative RA 6 types of PW 
Study IV RA(overall); ACPA-positive RA; ACPA-negative RA cold 
cold outdoor 
cold indoor  
 
 
The potential presence of interaction between two risk factors (A and B) was 
performed in study I, study II and study IV. Interaction on the additive scale was estimated 
by calculating the attributable proportion due to interaction (AP) as described by Rothman et 
al.87 A brief description of AP calculation is shown below. 
 
AP=RERI/RR11,  where RERI = RR11-RR10-RR01+1 
 
RERI corresponds to the relative excess risk due to interaction. RR11 refers to the 
relative risk among subjects exposed to both risk factors A and B. RR10 refers to the relative 
risk among subjects exposed to risk factor A but not B, and RR01 denotes the relative risk 
among subjects exposed to risk factor B but not A. Each relative risk is calculated using those 
who were unexposed to both risk factors as the reference group.  
 
All analyses were performed using the SAS software package, V.9.4 (SAS Institute, 
Cary, North Carolina, USA). 
 
7.5.1 Study I 
 
Odds ratios (ORs) and 95% confidence intervals (95%CI) for the development of 
ACPA-positive RA associated with two exposures (silica and current smoking or silica and 
past smoking) were calculated using unconditional logistic regression, adjusting for the 
matching variables (age and residential area). Those who were both never smokers and 
unexposed to silica were used as the reference group. Additional adjustments including 
alcohol consumption (non-drinkers, low, moderate, high), education (university degree, 
yes/no) and body mass index (<25 kg/m2 or ≥ 25 kg/m2) did not substantially alter the ORs 
and were therefore not retained in the final analyses. 
 
The interaction between silica exposure and pack-years of smoking (from 1 to 40 pack-
years) and between silica exposure and years of smoking cessation (from 5 to 30 years), were 
evaluated based on the principle of departure from additivity of effects.87 
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7.5.2 Study II 
 
For each type of physical workload, the odds of developing RA(overall), ACPA-
positive RA and ACPA-negative RA among the exposed group was compared with the 
corresponding odds in the unexposed group.  Separate analyses were performed for exposure 
status at baseline and exposure status at five years before baseline. Aside from the potential 
confounders described above, the 7 types of physical workload exposure were also 
considered as potential confounding factors for each other in this study. 
 
 We further examined whether exposure to more than one type of physical workload 
would increase the risk of developing RA. The subjects were categorized into 7 groups. 
Group 1(reference group) corresponds to those who reported they were not exposed to any of 
the physical workloads involved. Group 2, 3, 4, 5 and 6 corresponds to those who reported 
they were exposed to 1 type, 2 types, 3 types, 4 types, 5 types and 6 types of physical 
workload, respectively. Exposure to precision work was excluded from this analysis because 
the OR observed between exposure to precision work and the outcome was close to null. A p-
value for trend was obtained by treating the categorical variable (group 1-6) as a continuous 
variable in the logistic regression model. 
  
Interaction between HLA-DRB1 SE genes and different types of physical workload 
exposures at 5 years before baseline was performed, with regards to the risk of developing 
ACPA-positive RA. 
7.5.3 Study III 
 
For each type of physical workload, the odds of developing anti-CII positive RA or 
anti-CII negative RA was compared between the exposed group and the unexposed group 
(reference group). In this study, only cases recruited between 1996-2006 were included 
because the anti-CII level of cases recruited after 2006 are not yet measured. Controls 
included in this study were recruited from 1996 to 2014. A separate analysis in which both 
cases and controls were recruited from 1996-2006 was also done (data not shown). The 
results from this separate analysis had wider confidence intervals but relatively similar point 
estimates when compared to the final results shown in this study. 
7.5.4 Study IV 
 
The odds of developing RA (overall), ACPA-positive RA and ACPA-negative RA 
among those who reported they had worked in the cold environment (ever, current or past 
exposure) were compared with those who reported they had never worked in the cold 
environment (reference group).  
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The dose-response relationship between exposure to cold indoor work environment and 
risk of developing RA was investigated. The effect of duration, intensity, cumulative dose 
and cessation of working in cold indoor environment on the risk of developing RA were 
analyzed. Duration was quantified by the number of years working in cold indoor 
environment. Intensity was quantified by the number of hours per week. Cumulative dose 
was quantified by the number of work-years, which was calculated by multiplying duration 
with intensity. One work-year was equivalent to 2080 hours. Cessation was defined as the 
number of years the subjects had stopped working in the cold indoor environment. 
 
Several cut-off methods were used for categorizing number of years, number of hours 
per week and number of work-years. Arbitrary cut-off values as well as cut-off values based 
on the median and tertile values of the exposed controls were used. The trends were relatively 
similar across these three ways of categorization, but only arbitrary cut-off values with four 
categories were presented in the final results. P- values for trend were obtained by treating the 
categorical variable as a continuous covariate in the logistic regression model.  
 
Interaction between exposure to cold work environment and different types of physical 
workload was performed. We have collected information on physical workload exposure for 
two time points (i.e. baseline and five-years before baseline). In contrast, participants were 
asked to report two specific time periods in which they were exposed to cold work 
environment. Since there was difference in the temporal information on these two risk 
factors, two different methods of defining exposure to cold work environment were used. The 
first method was restricting both cold work environment exposure and physical workload 
exposure at 5 years before baseline. The second method was restricting only physical 
workload exposure at 5 years before baseline, while working in cold environment exposure 
was not restricted at any specific time point. 
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8 RESULTS 
8.1 SMOKING-SILICA INTERACTION AND RISK OF RA 
 
In addition to the previous finding on the interaction between cigarette smoking and 
silica, results from study I showed that this interaction depended on both the dose of smoking 
and the length of smoking cessation. The magnitude of the estimated silica-smoking 
interaction increase yhd as the pack-year of smoking increased, with the highest AP observed 
for smoking ≥28 pack-years (AP=0.7 (95%CI: 0.4-0.9)) (figure 2). The interaction between 
silica and smoking among ex-smokers who ceased smoking ≤ 10 years ago (AP=0.5 
(95%CI: 0.1-0.9)) was relatively similar to the silica-smoking interaction observed among 
current smokers (AP=0.5 (95%CI: 0.2-0.8)). The interaction between silica and smoking 
cessation was no longer statistically significant after >10 years of smoking cessation (AP=0.1 
(95%CI, -0.4-0.7)) (figure 3). 
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8.2 PHYSICAL WORKLOAD AND RISK OF RA 
 
Out of seven different types of occupational physical workload, six were associated 
with an increased risk of developing RA. ORs observed for these 6 types of physical 
workload ranged from 1.3 (95%CI: 1.1-1.4) to 1.8(95%CI: 1.6-2.0) (figure 4). The highest 
OR was observed for exposure to hands above shoulder level. Exposure to precision work 
was the only type of physical workload observed to be not associated with the risk of 
developing RA (1.1 (95%CI: 1.0-1.3)). Exposure to more types of physical workload was 
observed to be associated with higher risk of developing RA (p-value for trend <0.0001) 
(figure 5).  
 
 
 
 
 
Figure 4. Odds ratio of developing rheumatoid arthritis among participants exposed 
to physical workload compared to unexposed. 
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Figure 5. Odds ratio of developing RA across groups exposed to increasing 
number of types of physical workload compared to unexposed. 
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8.2.1 Physical Workload and Antibody Status 
 
The six types of physical workload observed to be associated with the risk of RA 
(overall) were also observed to be associated with both ACPA-positive and ACPA-negative 
RA. The ORs observed for ACPA-positive RA and ACPA-negative RA were relatively 
similar, except for precision work. The ORs for ACPA-positive RA ranged from OR=1.2 
(95%CI: 1.1-1.4) to OR=1.8 (95%CI: 1.6-2.0), while the ORs for ACPA-negative RA ranged 
from 1.4 (95%CI: 1.2-1.6) to 1.7(95%CI: 1.5-2.0). 
 
These 6 types of physical workload were also found to be associated with an increased 
risk of both anti-CII positive and anti-CII negative RA, even though the ORs observed for 
anti-CII positive had wide confidence intervals (figure 6). 
 
 
 
 
 
 
 
 
 
Figure 6. Odds ratio of developing anti-CII positive RA and anti-CII negative RA 
among participants exposed to physical workload compared to unexposed. 
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8.2.2 Physical Workload and HLA-DRB1 
 
With regards to the risk of developing ACPA-positive RA, interaction between HLA-
DRB1 shared epitope and physical workload (except precision work) was observed. The AP 
values ranged from 0.3(95%CI, 0.0-0.5) to 0.4 (95%CI, 0.2-0.5) (figure 7). 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Attributable proportion due to interaction (AP) between physical workload and the 
HLA-DRB1 shared epitope. Odds ratios correspond to the odds ratios associated with the 
risk of developing ACPA-positive RA among subjects with HLA-DRB1 shared epitope and 
exposed to physical workload compared to those unexposed to both factors. 
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8.3 WORKING IN COLD ENVIRONMENT AND RISK OF RA 
 
Working in cold environment was observed to be associated with an increased risk of 
developing RA (OR=1.5; 95%CI 1.4-1.7) (figure 8). Exposure to both indoor and outdoor 
cold work environment increased the risk of RA, but a dose-response relationship was 
observed only for exposure to cold indoor work. No major difference was found between the 
risk for two RA subtypes, namely ACPA-positive RA and ACPA-negative RA. Interaction 
(AP=0.3; 95%CI 0.1-0.5) was found between exposure to cold work environment and 
exposure to repetitive hand/finger movements at work.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Odds ratios of developing RA among subjects worked in cold environment, 
cold indoor environment and cold outdoor environment. 
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9 DISCUSSION 
9.1 MAIN FINDINGS AND IMPLICATIONS 
 
In study I we observed that the effect of silica-smoking interaction with regards to the 
risk of ACPA-positive RA depended on the dose of smoking and it could take more than 10 
years of smoking cessation for the silica-smoking interaction effect to disappear. The results 
strengthen the hypothesis that airborne exposures affecting the lungs play a role in the 
etiology of ACPA-positive RA. The findings also strengthen the rationale to advice both the 
public and those who are exposed to silica due to their occupation to avoid smoking.  
 
In study II we found that physical workload is associated with the risk of developing 
both ACPA-positive and ACPA-negative RA. This study identified physical workload as a 
potential new environmental risk factor for RA. Prior to this study, physical workload has not 
been shown to be associated with RA, but has been known as a risk factor of 
osteoarthritis.63,64 Osteoarthritis is a non-autoimmune joint disease. In contrast, RA is a more 
severe chronic disease in which excessive and uncontrolled inflammatory responses lead to 
self-destruction of human body tissues by the immune system. The involvement of the 
immune system in RA has resulted in immense number of researches focusing mainly on the 
immune aspects of RA etiology, while mechanical factors that directly affect the joints have 
generally been considered as unlikely contributing factors. The findings of study II highlight 
the importance of considering physical workload exposure as a risk factor not only for non-
autoimmune joint disease such as osteoarthritis, but also for inflammatory diseases such as 
RA. 
 
Study III was performed as an attempt to identify plausible biological mechanisms that 
could explain the association between physical workload and the risk of RA. We 
hypothesized that physical workload could injure the cartilage of the joints leading to immune 
reaction and production of antibodies against type-II collagen. However, no evidence was 
found in study III that suggests physical workload is associated with the development of 
anti-CII antibodies in RA. The findings may imply that the presence of anti-CII antibodies in 
RA is not due to lesions on the cartilage caused by mechanical forces on the joints around 5 
years before disease diagnosis. 
 
In study IV, we observed that working in cold environment is associated with the risk 
of developing RA. Whether cold environment has a role in causing RA disease is a 
commonly asked question and a concern from many RA patients. The findings from this 
study provide clues for this question, which has been lingered in human history for a long 
time. This study underscores the importance of taking the effect of cold environment on 
human physiological or immunity into considerations when studying the etiology of RA. 
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9.2 POTENTIAL BIOLOGICAL MECHANISMS 
 
No studies in the current literature have investigated the potential biological 
mechanisms underlying the association between physical workload or exposure to cold work 
environment and risk of developing RA. Nevertheless, the following hypothesized biological 
mechanisms are probably worth investigating in the future. 
 
Prolonged or repetitive postures or forces may exert excessive mechanical stress on the 
joints and the synovium. Mechanical stress could lead to protein denaturation. Under normal 
condition, the cells restore the denatured protein into their normal functional forms through 
upregulation of chaperones or heat shock proteins (HSP). Several heat shock proteins such as 
HSP60, HSP70 and HSP96 have been shown to be associated with RA.88-90 Interestingly, 
HSP-70 have been shown to be overexpressed after shear stress stimulation of RA synovial 
tissue.89  Based on the above-mentioned information, cellular dysregulations related to the 
disruption of the balance between protein denaturation rate and protein restoration rate by 
excessive mechanical stress could probably lead to chronic immune activation and diseases 
such as RA. 
 
Citrullination of peptides is considered as one of the pathogenic event that leads to the 
establishment of RA.91 Consequently, it is pivotal to understand what environmental factors 
trigger citrullination or other post-translational modifications leading to chronic 
inflammation. Since we observed that physical workload and cold work environment are 
associated with not only ACPA-positive RA but also ACPA-negative RA. This may imply 
that the exposures, physical workload and cold work environment, are probably not direct 
triggers of citrullination.  
 
Some researchers postulate that chronic inflammation in the pathogenesis of RA, 
particularly ACPA-positive RA, is not initiated in the joints but in other organs such as the 
lungs.91,92 It is hypothesized that some primary environmental exposures such as smoking 
could initiate citrullination in the lungs, which leads to the production of ACPAs and 
systemic immunity.92 As the systemic immunity proceeds, some secondary environmental 
exposures reach/hit the joints, which leads to lesions and localized chronic inflammation in 
the joints.93 Therefore, another potential biological mechanism that can explain the 
association between physical workload and risk of RA is: probably physical workload acts as 
the so-called “second-hit” in the course of RA disease pathogenesis. Although no evidence 
was found in study III to support the hypothesis that physical workload could induce lesions 
on the cartilage leading to anti-CII production, this hypothesis may still be worth 
investigating as there might be lesions on other components of the joints at another pre-RA 
time point. 
 
In study IV, a positive interaction was observed between repetitive hand/finger 
movement and working in cold environment with regards to the risk of developing RA. 
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Working in cold environment demands higher workload from the muscles, tendons and joints 
than working in normal condition. Human physiological responses to cold environment 
include shivering and vasoconstriction. Shivering augments heat production while 
vasoconstriction maintains the core body temperature and decreases the temperature on the 
skin and the joint.74 Lower temperature in the joint area may increase the viscosity of the 
synovial fluid,94 which may require extra force and energy to move the joints and lead to a 
higher risk of injury or higher protein denaturation rate in the cellular level. Moreover, the 
functions of immune cells depend on the availability of oxygen and nutrients. Exposure to 
cold environment might decrease blood circulation and supply of oxygen and nutrients to the 
fingers and joints, which are relatively far from the core body and are in demand of oxygen 
and nutrients to perform physical workload. Under such situation, hypoxia might occur in the 
joint extremities leading to chronic inflammation and RA. 
 
The causal relationship between RA and homeostasis of microbiome is still under 
investigation. A study reported that the microbiome in the gut and mouth of RA patients 
differs substantially from healthy controls.95 Another study has observed that physical 
exercise increases the gut microbial diversity in elite athletes (i.e. 40 professional rugby union 
players versus 46 more sedentary controls).96 It seems plausible that physical workload and 
cold work environment might also be associated with the homeostasis of gut microbiome, 
which may have a role in modulating immune response leading to RA. 
 
These are only a few examples of possible hypotheses that can be generated to guide 
future researches on RA etiology. When conducting future researches on RA etiology, taking 
the perspectives and experiences of RA patients as well as modifiable environmental risk 
factors into consideration would facilitate the translation of scientific findings into applicable 
preventive strategies.  
 
9.3 STUDY DESIGN 
9.3.1 Strengths 
 
All four studies in this thesis are based on the EIRA study, a population based case-
control study, in which incident cases in a defined geographical area are identified and 
controls are drawn randomly from the population at risk. This enhances the generalizability 
of the findings. All cases are incident and the time duration from the appearance of first 
disease symptom to diagnosis is relatively short (mean=10 months). In addition, only 
exposures prior to the appearance of the first disease symptom were considered and analyzed. 
These increase our confidence that the exposure we studied happened before disease onset, 
which complies with our main research aim of identifying risk factors for developing RA.  
Many potential confounding factors could be taken into considerations in all the analyses, 
owing to the possibility of retrieving information on many environmental/lifestyle factors 
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through questionnaires. The response rate for cases (94%) and controls (77%) are relatively 
high when compared with the general response rate of case-control studies in the literature. 
Nevertheless, as the participation proportion is higher among the cases than controls, 
potential selection bias cannot be ignored. 
9.3.2 Limitations 
9.3.2.1 Selection Bias  
 
The main concern of selection bias is connected to the 23% non-participation 
proportion among the controls. If these non-participating controls were likely to be those who 
were either exposed to physical workload or exposed to cold work environment(i.e. if the 
probability to be included in the study is associated with exposure), then the observed ORs in 
our studies would be overestimations.  
 
A previous study had acquired information on EIRA non-participants from registry 
data and observed that non-participation is associated with socioeconomic class.97 This 
observation offers one possible strategy to investigate the degree of such selection bias by 
performing stratification analysis based on educational level or occupational class and 
examine whether the risk estimates differ across strata. By employing this strategy, we 
observed that the ORs are robust across strata and we concluded that this selection bias is 
unlikely to have substantial impact on the observed associations.  
 
Another possible strategy to investigate the potential influence of such selection bias on 
our results is by conducting an “educated guess analysis”. We could calculate the limits of 
selection bias (1) by presuming that the 23% non-participating controls have similar exposure 
frequency as compared with the exposure frequency of the participating cases; (2) by finding 
the threshold exposure frequency of the non-participating control in order for the OR to be 
equal to null effect or 1.0. For example, the observed OR for hands above shoulder level is 
1.8 (95%CI, 1.6-2.0) and the observed exposure frequency of the participating cases is 30%. 
If we assume that the exposure frequency of the non-participating controls is also 30%, the 
estimated OR would be 1.5 (95% CI, 1.4-1.7). Based on the given example, we observed that 
even when the non-participating controls have similar exposure frequency as the participating 
cases, the positive association between physical workload and risk of RA would still remain 
statistically significant. Secondly, we also observed that the exposure frequency of the non-
participating controls should be unreasonably higher than the exposure frequency of the cases 
in order for the OR to reach 1.0 (table 7). This further strengthen our deduction that the 
observed positive association between physical workload or cold work environment and risk 
of RA is unlikely due to such selection bias. 
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Table 7. Exposure frequency of participating cases and controls and theoretical threshold 
frequency of non-participating controls 
Exposures  Observed Exposure Frequency Threshold Frequency  
 participating 
cases 
participating 
controls 
non-participating 
controls 
Repetitive Bending/turning 67% 55% >90% 
repetitive hand/finger 
movements 
71% 66% >80% 
lift more than 10kg 56% 45% >80% 
hands below knee level 23% 16% >40% 
hands above shoulder level 30% 20% >60% 
vibration 19% 14% >30% 
working in the cold 23% 18% >40% 
 
9.3.2.2 Misclassification of Exposures 
 
The exposure information is self-reported and collected through questionnaire. Physical 
workload and exposure to cold environment are two exposures that may be suspected by RA 
patients as possible factors causing their disease. Consequently, the cases may recall these 
exposures differently than the non-cases. This recall bias could lead to differential exposure 
misclassification and overestimated odds ratios.   
 
In the constituent papers of this thesis, we had investigated the likelihood of this 
potential recall bias. With regards to the physical workload exposure, we argued that the 
exposure we analyzed was categorized into a binary variable (i.e. exposed versus unexposed). 
This limits the influence of recall bias, because it is less likely for cases to over-report their 
exposure status (yes/no) than to over-report their exposure frequency and duration. As for the 
cold work environment exposure, we compared the occupations between the exposed cases 
and exposed controls. Since the occupations are comparable between these two groups, we 
concluded that the observed positive associations are unlikely due to such potential recall 
bias.  
 
An alternative method to investigate the strength of this potential recall bias is by 
conducting a multidimensional bias analysis.98 In this bias analysis, we would like to examine 
how the estimated odd ratio would change across different sensitivity values assigned for the 
exposure classification method used in the study. We assumed that the specificity for both the 
cases and controls is relatively high (approximately 90%), because if a subject who is truly 
unexposed to physical workload, it is unlikely for that subject to report it as exposed. In 
contrast, the sensitivity among the cases and controls is likely to be different, and likely to be 
higher for the cases than for the controls. 
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Given the presumptions above, a multidimensional bias analysis was performed for the 
exposure working with hands above shoulder level and the results are shown in figure 9. 
Based on the observed bias adjusted ORs, our observed positive association could be an 
overestimation if the sensitivity among the controls is lower than 40% and the sensitivity 
among the cases is above 70%, conditioning with a specificity of 90% for both cases and 
controls. Few studies have reported the sensitivity and specificity of physical workload 
questionnaire; nevertheless, the reported sensitivity and specificity of dichotomous 
questionnaire information on physical workload are relatively high, with sensitivity of around 
70%-90% and specificity of around 70%-100%.85,99 Notably these sensitivity and specificity 
were measured based on a population without a specific disease.  Given this information, we 
could deduce that the sensitivity for the controls in our study is likely to be greater than 50%, 
and the adjusted ORs with a sensitivity of higher than 50% in the controls suggest a positive 
association (figure 9). Multidimensional bias analysis was also performed for other physical 
workload exposures (data not shown). In brief, the adjusted ORs observed for hands below 
knee level and vibration demonstrate a similar trend as the OR observed for hands above 
shoulder level. The adjusted ORs observed for other types of physical workload reveal a 
higher probability of either no association or negative association.  
 
  
 
 
Although the multidimensional bias analysis provides more information on the 
potential impact of recall bias, it has some limitations. Firstly, the assigned values for 
sensitivity and specificity are based on educated guessing and there is no information 
available in the literature that gives a reliable sensitivity and specificity values for our data. 
Secondly, it does not provide information regarding which of the bias adjusted ORs is most 
likely to occur. The second limitation can be overcome through the use of probabilistic bias 
analysis; however, the accuracy of probabilistic bias analysis depends substantially on the 
chosen probabilistic distributions used to calculate the adjusted OR and these calculations are 
beyond the scope of this thesis.98 
Figure 9. The adjusted odds ratios across different sensitivities of exposure (i.e. hands above 
shoulder level) classification among cases and controls. Adjusted odds ratios highlighted in red are 
impossible values given the data and the combination of values assigned to the sensitivity and 
specificity. Se denotes sensitivity; Sp denotes specificity. 
Se 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1
Se Sp Sp 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
0.9 0.9 2.41 2.89 3.61 4.80 7.16 14.12 493.45 -14.98 -7.38
0.8 0.9 2.07 2.48 3.10 4.12 6.15 12.12 423.40 -12.85 -6.33
0.7 0.9 1.73 2.07 2.58 3.44 5.13 10.11 353.36 -10.73 -5.28
0.6 0.9 1.38 1.66 2.07 2.76 4.11 8.11 283.32 -8.60 -4.24
0.5 0.9 1.04 1.25 1.56 2.07 3.10 6.10 213.28 -6.47 -3.19
0.4 0.9 0.70 0.84 1.05 1.39 2.08 4.10 143.24 -4.35 -2.14
0.3 0.9 0.36 0.43 0.54 0.71 1.06 2.09 73.20 -2.22 -1.09
0.2 0.9 0.02 0.02 0.02 0.03 0.05 0.09 3.16 -0.10 -0.05
0.1 0.9 -0.33 -0.39 -0.49 -0.65 -0.97 -1.91 -66.88 2.03 1.00
Cases
Controls
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9.3.2.3 Misclassification of Disease 
 
RA is considered as a clinical syndrome that encompasses several disease subsets, 
which may have distinct inflammatory mechanistic pathways that result into a common 
clinical feature of persistent synovial inflammation and destruction of bone and cartilage.100 
Despite the complexity of RA, classification criteria for RA are developed, which facilitates 
research on RA.  The RA cases in study I-IV were classified based on the ACR 1987 or 
ACR 2010 criteria and were diagnosed by rheumatologists. Although ACR 2010 criteria has 
greater sensitivity in identifying early RA patients as compared with ACR 1987 criteria, only 
a very small proportion of cases (0.1%) fulfilled only the ACR 2010 but not ACR 1987. 
Consequently, the emergence of the ACR 2010 criteria may have an influence on identifying 
RA patients at an earlier stage, but would not result in differential misclassification of disease 
in this thesis. 
 
There is a possibility that some cases are misdiagnosed, but this likelihood is 
considered small since all cases were diagnosed by a rheumatologist. Even though 
accessibility to health care is free of charge in Sweden, some cases in the study area may not 
have been included. Based on our experience, this is mainly due to administrative reasons 
such as lack of time or change of personnel and among others. It seems unlikely that subjects 
who were exposed to silica, cigarette smoke, physical workload or cold work environment 
would have a different tendency in seeking medical care than those who were not exposed to 
these exposures. The proportion of invited cases that answered the questionnaire was high 
(94%). Overall, the likelihood that the exposures investigated in this thesis would influence 
the probability for a case to be included in the study is considered to be relatively small.  
 
9.3.2.4 Confounding 
 
A confounder is a factor that is associated with both the exposure and the outcome, but 
should not be an effect of the exposure nor the outcome. All studies in this thesis have taken 
many potential confounding factors (as listed in section 7.4) into consideration. However, 
similar to many other observational studies, residual confounding due to unmeasured 
confounding factors or due to imperfect information on the measured confounding factors 
cannot be ruled out. Presence of a bias due to confounding could, in principle, reverse or 
obscure the observed associations in this thesis.  
 
In this thesis, we found a positive association between physical workload and risk of 
RA. Other occupational factors such as occupational noise, air pollution and shift work are 
possible potential confounding factors that were not adjusted. A Finnish study reported that 
physical workload, occupational noise and shift work have a tendency to co-occur in the 
same occupational groups.101 Recently, a study conducted by Hedström et al. using EIRA 
study material,102 has found that permanent night shift work has a protective effect on RA 
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development, whereas rotating and day-oriented shift work increased the risk of ACPA-
positive RA but not ACPA-negative RA. Likewise, this study also did not adjust for physical 
workload.  Given this information, adjusting for permanent night shift work might increase 
the OR observed for physical workload and risk of RA. Adjusting for rotating and day-
oriented shift work might change the OR observed for physical workload and ACPA-positive 
RA towards null but not for physical workload and ACPA-negative RA. 
 
In study IV, we found an association between working in cold environment and risk of 
RA. The exposure in this study is self-reported and rather subjective. Many potential 
confounding factors that are closely related to the subjective feeling of cold have not been 
taken into consideration. A few example of these unmeasured potential confounding factors 
are temperature, barometric pressure, humidity, unknown dietary habits and unknown 
physiological characteristics. Although these unmeasured factors are known to be related to 
the exposure (i.e. working in cold environment), their associations with the outcome (i.e. risk 
of developing RA) have not been studied, and are thus unknown. Nonetheless, as these 
unmeasured potential confounding factors were not taken into account in the analysis, we 
could not distinguish whether subjective feeling of cold or other relevant elements such as 
temperature or humidity is more relevant to the development of RA. 
9.4 STATISTICAL ESTIMATES 
 
The odds ratios derived from case-control study can sometimes mirror the incidence 
rate ratios derived from a cohort study performed in the same study base. This depends on 
how the controls are sampled from the study base.103 When controls are drawn from the 
source population in the beginning of the follow-up time, then the odds ratio approximates 
risk ratio, since the controls provide an estimate of the exposure prevalence among persons at 
risk.  When controls are drawn from the source population at the end of the observation 
period, then the odds ratio is approximately equal to rate ratio if the outcome is rare. When 
controls are drawn from the source population at the same time as a case arise (i.e. density 
sampling), and a control may at later time become a case, then the odds ratio will provide an 
approximate estimate of the incidence rate ratio, which is similar to what would have been 
observed in a cohort study conducted on the same study base. This is because the controls 
selected using such incidence density sampling technique provides an estimate of the ratio of 
exposed to unexposed person-time. In the EIRA study, at each time a case is identified, 
controls are randomly selected from the Swedish population register. Accordingly, the odds 
ratios reported in our studies, in principle, estimate the incidence rate ratio of developing RA, 
conditioning on absence of substantial selection bias among controls. 
 
Attributable proportion due to interaction (AP) was used to evaluate the potential 
presence of biological interaction between two risk factors.  AP is calculated based on the 
principle of departure from additivity of effect. According to this principle, if the risk among 
those who are exposed to both two risk factors is greater than the sum of the individual risks 
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conferred by each of the two factors in the absence of the other, then this provides evidence 
of sufficient cause interaction.87,104 In study IV, an AP value of 0.3 was observed for the 
interaction between exposure to cold work environment and repetitive hand/finger 
movements. Presuming that these factors are causal, this AP value would suggest that around 
30% of those who were exposed to both cold work environment and repetitive hand/finger 
movements developed RA, because both these two risk factors co-occur in mechanisms 
leading to the disease. This not only gives insight on the etiology of RA, but also has 
important public-health implications. In study II, the AP value between exposure to hands 
above shoulder level and having the shared epitope gene was observed to be 0.4 regarding the 
risk of developing ACPA-positive RA. This implies that 40% of the ACPA-positive cases 
that emerged among those who have the shared epitope gene and were exposed to hands 
above shoulder level could have been prevented, if these subjects had avoided the exposure 
hands above shoulder level. 
9.5 SIGNIFICANCE  
 
For experimental researches, the strength of evidence partly depends on whether the 
hypothesis is verified through in vitro or in vivo experiments. The experiments performed on 
living organisms such as mice are usually perceived as more valid than experiments 
performed using cells. However, scientific knowledge acquired through mice experiments are 
not always applicable to humans. To ensure that scientific research results from the lab can be 
applied to humans, clinical or epidemiological research are needed. On the other hand, 
epidemiological research results would be more convincing if there are available 
experimental evidence that support the causal relationship it investigates.  
 
In this thesis, study I strengthened the research hypothesis that airway exposure such 
as cigarette smoke and silica are critical for the etiology of ACPA-positive RA. The causal 
relationship between airway exposure and RA has been investigated in many studies.92,105-107 
In contrast, in study II and study IV, we have identified two new environmental risk factors 
for RA, namely physical workload and working in cold environment. Since these findings are 
relatively new, supporting experimental data are in demand to support the underlying causal 
relationship. As an attempt to provide a mechanistic explanation to these findings from 
epidemiology, we investigated the relationship between physical workload and presence of 
anti-CII in RA, but we did not find evidence suggesting an association between anti-CII 
antibodies and RA (study III). In short, the significance of this thesis is not to confirm 
whether physical workload or cold work environment is a cause of RA, but rather it provides 
clues on two new risk factors for RA and forms the foundation for future interventional or 
experimental studies for the analysis of causation. 
 
Future research can focus on validating the findings of this thesis using other study 
populations, or using other methods to assess the exposure such as using a job exposure 
matrix instead of information from self-reported questionnaire. Future research may also 
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focus on drawing plausible cellular etiologic pathways and test them using laboratory 
experiments.  
9.6 CONCLUSION 
 
The findings of this thesis not only further confirm that lung exposures(e.g. cigarette 
smoke and silica) play an important role in the etiology of ACPA-positive RA, but also 
identified two new environmental risk factors for RA, namely physical workload and cold 
work environment.  Whether physical workload and cold work environment are contributing 
factors to RA development has previously not been investigated in systematically designed 
studies with enough statistical power and represents a frequently asked question from RA 
patients. This thesis has provided an unprecedented piece of scientific evidence to support 
this unaddressed concern. In addition, the results are also valuable for creating relevant 
etiologic hypotheses concerning the disease etiology of RA which can be tested using 
interventional or experimental studies. 
9.7 REFLECTION ON RESEARCH ETHICS 
 
The benefits of conducting the epidemiologic studies in my research project outweigh 
the risks. My research projects provide new knowledge on modifiable risk factors for RA. 
The gained knowledge may contribute to better understanding of the natural history of RA, to 
RA prevention and to improved health care. Unlike intervention studies, the studies of my 
research project does not involve invasive procedures done on patients. However, my studies 
carry a potential risk of breaching personal data which may harm participants’ integrity. This 
would happen (1) when personal identity data are accessed by unauthorized persons; (2)when 
data are presented in a very detailed manner in which the identity of certain study subjects 
become traceable; and (3) when the data are misused politically. If breach of confidentiality 
happened, it would damage not only the integrity of the participants but also the trust the 
participants have on scientific research, which would impair healthcare research and 
development.  
 
To safeguard the integrity of participants, proper storage and handling of data is 
required. The data in EIRA study are stored and analyzed in a data-security computer system, 
in which unauthorized persons are unable to access. This prevents possible leakage of data in 
case the computers in which the analyses were performed are lost. The researchers 
performing the analyses (e.g. myself) are blinded from the Swedish personal identity number 
of all participants; thus, preventing any data misuse by any researcher analysing the data. 
Lastly, the result of the data were presented in a comprehensive and summarized manner in 
which no specific participants are potentially identifiable based on the scientific manuscripts 
or other relevant publications. 
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